Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using CALR mAb against human CALR (AA: 18-417) recombinant protein. (Expected MW is 49.4 kDa)Application
Figure 3:Western blot analysis using CALR mAb against HEK293 (1) and CALR (AA: 18-417)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Western blot analysis using CALR mouse mAb against Hela (1), MCF-7 (2), NIH/3T3 (3), HepG2 (4), Jurkat (5), Y-79 (6), and C6 (7) cell lysate.Application
Figure 5:Flow cytometric analysis of Hela cells using CALR mouse mAb (green) and negative control (red).Application
Figure 6:Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using CALR mouse mAb with DAB staining.Application
Figure 7:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CALR mouse mAb with DAB staining.| Product Name | CALR |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | RO; CRT; SSA; cC1qR; HEL-S-99n |
| Immunogen | Purified recombinant fragment of human CALR (AA: 18-417) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Alternative Names | RO CRT SSA cC1qR HEL-S-99n |
|---|---|
| Molecular Weight(MW) | 48.1kDa |
| Entrez Gene | 811 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using CALR mAb against human CALR (AA: 18-417) recombinant protein. (Expected MW is 49.4 kDa)
Application
Figure 3:Western blot analysis using CALR mAb against HEK293 (1) and CALR (AA: 18-417)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Western blot analysis using CALR mouse mAb against Hela (1), MCF-7 (2), NIH/3T3 (3), HepG2 (4), Jurkat (5), Y-79 (6), and C6 (7) cell lysate.
Application
Figure 5:Flow cytometric analysis of Hela cells using CALR mouse mAb (green) and negative control (red).
Application
Figure 6:Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using CALR mouse mAb with DAB staining.
Application
Figure 7:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using CALR mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
